-The Business Standard The recent US-India friction over trade is being driven by Big Pharma Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors. Entirely missing from the discourse has been an equally potent factor with wholly foreign origins: the hijacking of the economic policy...

-Press Information Bureau (Ministry of Tribal Affairs) Government has disposed of 31, 06,690 claims by the end of Dec-2013 out of 36,54,420 claims filed under Scheduled Tribes and other Traditional Forest Dwellers (Recognition of Forest Rights) Act -2006, commonly known as Forest Rights Act (FRA). This is 85.01% of the total claims filed under the Act. Out of the claims disposed off, 14,18,078 titles (13,95,647 individual titles and 22,431...

-The Hindu Chennai: With U.S Trade Representative Michael Froman set to announce a trade enforcement action tied to India, the highly influential U.S Chamber of Commerce has lashed out at India's recent pattern of pharma patent denials, pointing out that the country's actions "are not about access to medicine." In the case of Swiss drug-maker Novartis, whose cancer drug's patent protections were dismissed by the Supreme Court, the chamber has argued that...

-The Telegraph New Delhi: India will seek changes to international copyright regulations so that students and researchers can procure photocopies of expensive books without having to pay royalties, a senior government source said. Come December, he said, the Union human resource development ministry will ask the World Intellectual Property Organisation (Wipo) to relax its norms that protect authors' and publishers' commercial rights over their books. The ministry will suggest at the next general...

-The Business Standard Angelina Jolie has inadvertently highlighted a key question about patenting Angelina Jolies recent double mastectomy was obviously a very radical decision. It is unusual for a healthy person to opt for pre-emptive surgery to avert the probability, however high it may be, of getting cancer. The tests Jolie relied on are also at the heart of a legal battle, which could affect US biotech patenting norms. Since the US...